Viking Therapeutics Inc (NASDAQ: VKTX) is 278.67% higher on its value in year-to-date trading and has touched a low of $8.28 and a high of $99.41 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The VKTX stock was last observed hovering at around $68.16 in the last trading session, with the day’s gains setting it 2.31%.
Currently trading at $70.47, the stock is 14.37% and 20.04% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 7.97 million and changing 3.39% at the moment leaves the stock 34.23% off its SMA200. VKTX registered 422.39% gain for a year compared to 6-month loss of -0.17%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 8.82% gain in the last 1 month and extending the period to 3 months gives it a 33.62%, and is 5.60% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.04% over the week and 6.33% over the month.
Viking Therapeutics Inc (VKTX) has around 27 employees, a market worth around $7.81B and $0.00M in sales. Distance from 52-week low is 751.09% and -29.11% from its 52-week high. The company has generated returns on investments over the last 12 months (-10.50%).
The EPS is expected to shrink by -8.42% this year.
Viking Therapeutics Inc (VKTX) Top Institutional Holders
517.0 institutions hold shares in Viking Therapeutics Inc (VKTX), with institutional investors hold 80.04% of the company’s shares. The shares outstanding are 110.80M, and float is at 103.61M with Short Float at 16.54%. Institutions hold 75.18% of the Float.
The top institutional shareholder in the company is FMR LLC with over 16.54 million shares valued at $876.8 million. The investor’s holdings represent 15.9876% of the VKTX Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 10.1 million shares valued at $535.26 million to account for 9.7599 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 6.03 million shares representing 5.8248% and valued at over $319.45 million, while STATE STREET CORP holds 4.9513 of the shares totaling 5.12 million with a market value of $271.54 million.
Viking Therapeutics Inc (VKTX) Insider Activity
The most recent transaction is an insider sale by SINGLETON J MATTHEW, the company’s Director. SEC filings show that SINGLETON J MATTHEW sold 10,300 shares of the company’s common stock on Sep 20 ’24 at a price of $69.50 per share for a total of $0.72 million. Following the sale, the insider now owns 9500.0 shares.
Viking Therapeutics Inc disclosed in a document filed with the SEC on Sep 20 ’24 that Lian Brian (President & CEO) sold a total of 216,130 shares of the company’s common stock. The trade occurred on Sep 20 ’24 and was made at $70.83 per share for $15.31 million. Following the transaction, the insider now directly holds 2.3 million shares of the VKTX stock.
Still, SEC filings show that on Sep 20 ’24, Lian Brian (Officer) Proposed Sale 216,130 shares at an average price of $18.41 for $3.98 million. The insider now directly holds shares of Viking Therapeutics Inc (VKTX).
